Am J Perinatol 2010; 27(10): 785-790
DOI: 10.1055/s-0030-1254237
© Thieme Medical Publishers

The Accuracy of Late Third-Trimester Antenatal Screening for Group B Streptococcus in Predicting Colonization at Delivery

Craig V. Towers1 , Pamela J. Rumney2 , Tamerou Asrat1 , Christine Preslicka1 , Mark G. Ghamsary3 , Michael P. Nageotte1
  • 1Long Beach Memorial Women's Hospital, Long Beach, California
  • 2University of California, Irvine Medical Center, Orange, California
  • 3Loma Linda University, Loma Linda, California
Further Information

Publication History

Publication Date:
10 May 2010 (online)

ABSTRACT

We reevaluated the accuracy of antenatal group B streptococcal (GBS) culture results in predicting colonization at the time of delivery in a general practice setting. Patients who had late third-trimester antenatal GBS cultures were prospectively identified. A repeat GBS culture was performed when admitted in labor using a strict protocol and laboratory analysis. Sensitivity, specificity, and positive and negative predicative values were calculated. In comparing the office culture results to the intrapartum cultures in 1472 patients, the sensitivity was 51%, specificity 94%, positive predictive value 67%, and negative predictive value 88%. The antenatal positive culture rate of 15.4% was significantly lower than the 20.1% intrapartum positive culture rate. There were 144 patients (9.8%) who had false-negative antenatal culture results. Through office survey, several aspects of the recommended antenatal procedures were not followed. The results support the previously reported high specificity and negative predictive values for this test. The near 10% false-negative rate with the significant difference between the antenatal versus intrapartum positive culture rate highly suggests that late third-trimester culture accuracy may be affected if the specified procedures are not completely followed, including the culturing technique, the use of recommended transport medium, and the laboratory culture protocol.

REFERENCES

  • 1 Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control Prevention.  MMWR Recomm Rep.. 1996;  45(RR-7) 1-24
  • 2 The American College of Obstetricians and Gynecologists . Prevention of early-onset group B streptococcal disease in newborns.  Int J Gynaecol Obstet. 1996;  54 197-205
  • 3 Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.  Pediatrics. 1997;  99 489-496
  • 4 Schrag S J, Zell E R, Lynfield R Active Bacterial Core Surveillance Team et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.  N Engl J Med. 2002;  347 233-239
  • 5 Main E K, Slagle T. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols.  Am J Obstet Gynecol. 2000;  182 1344-1354
  • 6 Gilson G J, Christensen F, Romero H, Bekes K, Silva L, Qualls C R. Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation.  J Perinatol. 2000;  20(8 Pt 1) 491-495
  • 7 Towers C V, Suriano K, Asrat T. The capture rate of at-risk term newborns for early-onset group B streptococcal sepsis determined by a risk factor approach.  Am J Obstet Gynecol. 1999;  181(5 Pt 1) 1243-1249
  • 8 Brozanski B S, Jones J G, Krohn M A, Sweet R L. Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis.  Obstet Gynecol. 2000;  95 496-501
  • 9 Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.  MMWR Recomm Rep.. 2002;  51(RR-11) 1-22
  • 10 The American College of Obstetricians and Gynecologists . Prevention of early-onset group B streptococcal disease in newborns.  Int J Gynaecol Obstet. 2003;  81 115-122
  • 11 Boyer K M, Gadzala C A, Kelly P D, Burd L I, Gotoff S P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.  J Infect Dis. 1983;  148 802-809
  • 12 Yancey M K, Schuchat A, Brown L K, Ventura V L, Markenson G R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery.  Obstet Gynecol. 1996;  88 811-815
  • 13 Edwards R K, Clark P, Duff P. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates.  Obstet Gynecol. 2002;  100 540-544
  • 14 McNanley A R, Glantz J C, Hardy D J, Vicino D. The effect of intrapartum penicillin on vaginal group B streptococcus colony counts.  Am J Obstet Gynecol. 2007;  197 583.e1-583.e4
  • 15 Orafu C, Gill P, Nelson K, Hecht B, Hopkins M. Perianal versus anorectal specimens: is there a difference in Group B streptococcal detection?.  Obstet Gynecol. 2002;  99 1036-1039
  • 16 Jamie W E, Edwards R K, Duff P. Vaginal-perianal compared with vaginal-rectal cultures for identification of group B streptococci.  Obstet Gynecol. 2004;  104(5 Pt 1) 1058-1061
  • 17 Petrova A, Smulian J C, Ananth C V. Obstetrician preferences for prenatal strategies to reduce early-onset group B streptococcal infection in neonates: a population-based survey.  Am J Obstet Gynecol. 2002;  187 709-714

Craig V TowersM.D. 

P.O. Box 8400, Huntington Beach

CA 92615

Email: drtowers@rbcpress.com

    >